10min Soothes Digestive Discomfort • Revives natural hunger signals---Lifting Skyward to Soothe the Core

$9.90 $3.90
Add to WishlistCompare
Availability: In Stock Pre order Out of stock

Hurry up! Sale Ends in

%-D%!D:Day,Days; %-H%!H:hour,hours; %-M%!M:min,mins; %-S%!S:sec,secs;

    Eight-Section Brocades: Lifting Skyward to Soothe the Core

    Biomechanical Optimization of Digestive Axes

    The Course is Designed Because

    Vibration stimulates the Yongquan acupoint, activating the kidney’s dual functions:
    Core Mechanism: Spleen-Stomach Synergy
    In TCM theory, this movement:
    • Elevation Phase: Activates SP-4 (gong sun xue) → Upward nutrient transport (spleen function)
    • Depression Phase: Stimulates ST-25 (tian shu xue) → Downward waste excretion (stomach function)
    • Pancreatic Link: Twisting motion enhances splenic artery perfusion (J Gastroenterol)

    This Course is For You If

    White-collar workers with lunchtime fatigue
    ✓ Chronic dieters with weight-loss resistance
    ✓ Diabetes/pre-diabetes patients
    ✓ Elderly with sarcopenic obesity
    ✓ Women with menstrual volume dysregulation
    ✓Lrritable bowel syndrome
    ✓Metabolic dysfunction
    ✓Chronic fatigue
    ✓Visceral ptosis

    Course Includes

    Core Practice
    • 1992 Master Tape: Archival 480p footage with modern kinesiology overlay
    • Movement Deconstruction:
      » Phase 1: Diaphragmatic descent (spleen compression)
      » Phase 2: Oblique muscle engagement (stomach torsion)
    Optimal Scheduling
    • 7-9AM (Stomach Time) Food stagnation prevention
    • 9-11AM (Spleen Time) Nutrient assimilation boost

    How to Watch After Purchase:

    1. Auto-send with mobile-ready files
    2. Industry-specific modules in one package

    Reminder 

    Consistent daily practice (AM/PM) is critical for cumulative benefits. Interruptions >72hrs may require technique reassessment.
    Disclaimer:

    This course complements but does not replace medical treatment. Consult physicians for pathologies. Lab values monitored in trials excluded severe renal impairment (eGFR<30).